| Literature DB >> 18471110 |
Abstract
The drug discovery programs that led to the development of the triptans were determined by the membership of the American Headache Society to be the most important breakthrough in headache medicine in the last 50 years. Dr. Humphrey, who spearheaded the drug discovery, recounts the pioneering work that took place and examines its therapeutic impact.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18471110 DOI: 10.1111/j.1526-4610.2008.01097.x
Source DB: PubMed Journal: Headache ISSN: 0017-8748 Impact factor: 5.887